Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Cochlear ( (AU:COH) ) has provided an announcement.
Cochlear Limited announced the cessation of 500 ordinary fully paid securities as part of an on-market buy-back, effective September 30, 2025. This move is part of the company’s capital management strategy, which may impact its financial structure and shareholder value, reflecting its commitment to optimizing capital allocation.
The most recent analyst rating on (AU:COH) stock is a Sell with a A$280.00 price target. To see the full list of analyst forecasts on Cochlear stock, see the AU:COH Stock Forecast page.
More about Cochlear
Cochlear Limited operates in the medical device industry, specializing in the development and manufacture of implantable hearing solutions. The company is a leader in hearing implants, focusing on providing innovative solutions to enhance hearing for individuals with hearing loss.
Average Trading Volume: 141,051
Technical Sentiment Signal: Hold
Current Market Cap: A$18.27B
See more insights into COH stock on TipRanks’ Stock Analysis page.